Provider review
AgelessRx review
A real microdose line where every published price is a four-month prepay.
The microdose tirzepatide is also dearer than the general program at the identical plan length, so the low-dose line is the premium one.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
AgelessRx
$159/mo microdose tirz — four-month prepay
- Vs median
- $10/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Microdosing is a first-class product line here rather than an afterthought, with two separately titled products and a longevity-first framing that genuinely matches what a low-dose reader is after. It is also the most prepay-dependent pricing here: every published figure is a four-month plan billed in one charge, and the monthly and two-month rungs the company says it offers appear nowhere. A site-wide banner sells the microdose figure as the lowest price ever while publishing no regular price to compare it to — and at matched plan length that microdose costs more than the general GLP-1 program.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a longevity-framed practice with an in-house clinical team and a named medical director
- You are content to pay four months up front, which is the only way any published price is available
- You want the option of moving between compounded and brand-name products without changing provider
Look elsewhere if
- You want a monthly rate — none is published for any GLP-1 product on the site
- You were choosing the microdose to spend less than the general program, because at matched plan length it costs more
- You want to see the real ladder before handing over health data, since checkout sits behind an intake quiz
What it actually costs
Price as published
Microdosing Tirzepatide from $159/mo, which the card itself says applies to a four-month plan billed in full (about $636 up front) · Semaglutide Microdosing from $99/mo with no plan length published · the combined GLP-1s Rx program from $139/mo, again on the four-month plan. Monthly and two-month plans are stated to exist and their prices are published nowhere
- Vs median
- $10/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Same price at every dose
One figure regardless of how much drug you take. Reassuring if you expect to titrate upward, and the least economical structure on this page if you do not: a quarter dose costs what a full one does.
88 of the 373 programs we track price a small dose this way. The row records the named microdose tirzepatide priced above the general GLP-1 program at the identical plan length, so the low-dose line is the premium product here. Every published figure is a four-month prepay billed in full and the monthly rungs the provider says exist are published nowhere, which is why nothing is readable as a monthly rate before intake.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Optional
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Microdosing is a first-class product line with two separately titled, separately priced products rather than an afterthought inside a weight-loss plan
- The price card openly states that the figure applies to a four-month plan billed in full, rather than passing a prepay rung off as a monthly rate
- A named medical director and an in-house clinical team rather than a gig-marketplace prescriber network
- Genuinely broad metabolic catalog — compounded GLP-1s, metformin, B12 and lipotropics, plus branded Wegovy and Zepbound — so a patient can move between compounded and FDA-approved options without changing provider
- Publishes a dated outcomes disclaimer naming its survey sample and date range instead of an unsourced success claim
- Explicitly supports transitioning from microdosing to a full dose with the same provider
Pharmacy, labs and oversight
AgelessRx does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What AgelessRx publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
AgelessRx is a longevity-focused telehealth company based in Ann Arbor, Michigan, selling prescription longevity and metabolic products including compounded GLP-1s, microdosed semaglutide and tirzepatide, NAD+, metformin, sermorelin, biological-age testing, and access to branded Wegovy and Zepbound. Care is delivered by what it describes as a fully in-house medical team under a named medical director, entirely online with no in-person visit. Compounding is done by an unnamed U.S.-licensed, LegitScript-certified pharmacy partner; no 503A or 503B designation is given. Plans are cash-pay subscriptions in monthly, two-month and four-month lengths, pausable or cancellable at any time, and HSA/FSA eligible.
The honest cons
Microdosing Tirzepatide at $159/mo costs MORE than the general GLP-1s Rx program at $139/mo on the identical four-month plan length — the microdose line is the premium product here, not the economy one
- Every published GLP-1 price is a four-month prepaid rung. The monthly and two-month prices AgelessRx says exist are published nowhere on the public site
- A site-wide banner sells $159 as the "lowest price ever" while no regular price is published anywhere to substantiate the claim — the rendered page and raw HTML were both searched for a struck-through or comparison figure and neither carries one
- No milligram figure is published for what any microdose price buys
- The compounding pharmacy is described only as LegitScript-certified and is never named; no 503A/503B designation is given
- Checkout sits behind an intake quiz on a separate application, so a shopper cannot see the real ladder without handing over health data first
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
AgelessRx is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#51 of 373
Ordered with the companies that pay us first, and AgelessRx is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- Microdosing tirzepatide
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
MadeMed
$239/mo flat
- Vs median
- $70/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Same price at every dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the MadeMed review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.